Company Overview of Ablexis, LLC
Ablexis, LLC, a biotechnology company, provides a platform for human antibody drug discovery and development. The company offers AlivaMab Mouse, a transgenic mouse platform for the discovery and development of therapeutic antibodies to treat human diseases. It commercializes its platform through creative partnering strategies to biotechnology and pharmaceutical companies. The company was founded in 2009 and is based in San Francisco, California.
409 Illinois Street
San Francisco, CA 94158
Founded in 2009
Key Executives for Ablexis, LLC
Ablexis, LLC Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ablexis, LLC, please visit www.ablexis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.